CD4 and systemic lupus erythematosus: These results suggest that the elevation of the glycolytic pathway and OXPHOS in SLE CD4+ T cells is not a secondary effect of autoantibody exposure or differentiation, but rather an incidental effect associated with SLE pathogenicity.